Dudediligence.

Sight Sciences, Inc

SGHTNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$20.2MSep ’24$19.1MDec ’24$17.5MMar ’25$19.6MJun ’25$19.9MSep ’25$20.4MDec ’25$19.7MMar ’26$23.4MJun ’26
Net income, by quarter
−$11.1MSep ’24−$11.8MDec ’24−$14.2MMar ’25−$11.9MJun ’25−$8.2MSep ’25−$4.2MDec ’25−$13.0MMar ’26−$4.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$49.0M$71.3M$81.1M$79.9M$77.4M
Gross profit$40.3M$59.0M$69.2M$68.3M$66.7M
Operating income−$51.5M−$84.0M−$57.3M−$50.5M−$37.1M
Net income−$63.0M−$86.2M−$55.5M−$51.5M−$38.4M
Operating cash flow−$52.5M−$76.0M−$47.2M−$22.4M−$29.7M
Free cash flow−$53.4M−$76.9M−$48.0M−$22.7M−$29.9M
Cash$260.7M$185.0M$138.1M$120.4M$92.0M
Debt$32.7M$33.3M$33.9M$39.4M$40.3M
Shares outstanding47.5M48.3M49.1M50.9M53.5M